Sangamo Therapeutics Reports First Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Sangamo Therapeutics Reports First Quarter 2019 Financial Results

Sangamo Therapeutics (SGMO) Misses Q1 EPS by 16c, Revenues Miss

May 8, 2019 4:03 PM EDT

Sangamo Therapeutics (NASDAQ: SGMO) reported Q1 EPS of ($0.41), $0.16 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $8 million versus the consensus estimate of $22.82 million.

"With recent encouraging clinical data in hemophilia A gene therapy and ex vivo gene-edited... More